Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-03-18FDA Approved: FENOFIBRATE — Original Application (Laurus Labs Limited)
The FDA approved Laurus Labs Limited's original application for a generic fenofibrate product, granting approval for a generic version of fe…
-
FDA approval · 2020-02-24FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's supplemental application for Omega-3-acid ethyl esters.
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA) [Phase 2, Phase 3]
Phase 2/3 trial updates the lipid-regulating effects of 1-Methylnicotinamide (1-MNA) in hypertriglyceridemia.
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: The Impact of Omega Three Fatty Acids on Vascular Function in HIV [Phase 4]
Phase 4 trial evaluating the impact of omega-3 fatty acids on vascular function in individuals with HIV and high triglyceride levels; study …
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) [Phase 3]
Phase 3 trial update for CaPRe in lowering very high triglycerides (TRILOGY 1) completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-01-17FDA Approved: FENOFIBRATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's fenofibrate generic under an original ANDA (ANDA213252).
-
FDA approval · 2019-12-09FDA Approved: FENOFIBRATE — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for fenofibrate (generic) under ANDA 202252.
-
FDA approval · 2019-11-26FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for Gemfibrozil submitted by Exelan Pharmaceuticals, Inc., likely updating the product labeling.
-
FDA approval · 2019-10-30FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for fenofibrate, bringing a generic fenofibrate product to approval status.
-
FDA approval · 2019-10-25FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's supplemental application for fenofibrate (generic fenofibrate) under ANDA209950, resulting …
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults [NA]
Clinical trial assessing a beverage intervention for Hispanic adults; completed with posted results in 2019, focusing on obesity and hyperch…
-
FDA approval · 2019-09-23FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for fenofibrate (generic). This action grants an additional approval to the AND…
-
FDA approval · 2019-09-23FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC (ANDA 200264), authorizing the gener…
-
FDA approval · 2019-09-23FDA Approved: FENOFIBRATE — Supplemental Application (AvKARE)
The FDA has approved a supplemental application for AvKARE's fenofibrate product, signaling an update to the approved formulation/manufactur…
-
FDA approval · 2019-09-23FDA Approved: FENOFIBRATE — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for fenofibrate from Leading Pharma, LLC (ANDA).
-
FDA approval · 2019-09-23FDA Approved: FENOFIBRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fenofibrate filed by Aurobindo Pharma Limited, approving changes to the generic fenofibrate prod…
-
FDA approval · 2019-09-19FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for fenofibrate from Cipla USA Inc. The approval indicates an update or addition via a supplemental …
-
FDA approval · 2019-09-06FDA Approved: FENOFIBRATE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original application for fenofibrate by Dr. Reddy's Laboratories Inc., authorizing the product as a generic.
-
FDA approval · 2019-08-15FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for fenofibrate by Mylan Pharmaceuticals, confirming continued access to this generic triglyceride-l…
-
FDA approval · 2019-08-09FDA Approved: FENOFIBRATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic's fenofibrate as an Original Application (ANDA). The generic fenofibrate is approved for treating lipid disorders such …
-
FDA approval · 2019-08-07FDA Approved: OMEGA-3-ACID ETHYL ESTER — Original Application (Bionpharma Inc.)
FDA approved the original ANDA for Omega-3-acid ethyl esters from Bionpharma Inc., establishing a generic prescription product indicated to …
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Efficacy of MND-2119 in Participants With Hypertriglyceridemia [Phase 3]
Phase 3 trial update on efficacy of MND-2119 in participants with hypertriglyceridemia has been completed.
-
FDA approval · 2019-07-10FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's generic omega-3-acid ethyl esters under an ANDA to reduce triglyceride levels in adults with severe hypertr…
-
FDA approval · 2019-05-15FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for fenofibrate from Lupin Pharmaceuticals, Inc. under the drug’s existing approval.
-
FDA approval · 2019-05-15FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc., marking a regulatory action on thi…